For citations:
Dzhanyan IA, Olisov OD, Antonova EY, Novruzbekov MS, Savchenko IV, Moroz EA, Laktionov KK, Romanova KA, Yudin DI, Khagazheeva MN, Breder VV. Effectiveness and safety of Atezolizumab and Bevacizumab as conversion therapy for unresectable or advanced HCC in real-world clinical practice in Russia: Multicenter retrospective observational study. Meditsinskiy sovet = Medical Council. 2025;(21):36-43. (In Russ.) https://doi.org/10.21518/ms2025-513

































